In a recent study, 80 μM EGCG was shown to inhibit lung cancer cell proliferation by suppressing NF-kB signaling in a mouse xenograft model, which was potentiated with coadministration by the NF-κB inhibitor BAY11-7082. This evidence concerns the gene NFKB1 and lung cancer.